GSRRX
Price
$12.74
Change
-$0.05 (-0.39%)
Updated
Sep 20 closing price
VFIAX
Price
$527.71
Change
-$1.02 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

GSRRX vs VFIAX

Header iconGSRRX vs VFIAX Comparison
Open Charts GSRRX vs VFIAXBanner chart's image
Goldman Sachs Rising Dividend Gr R
Price$12.74
Change-$0.05 (-0.39%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Admiral
Price$527.71
Change-$1.02 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GSRRX vs VFIAX Comparison Chart
Loading...
VS
GSRRX vs. VFIAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRRX is a Buy and VFIAX is a Buy.

FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.24T vs. GSRRX (499M). GSRRX pays higher dividends than VFIAX: GSRRX (2.56) vs VFIAX (1.32). GSRRX was incepted earlier than VFIAX: GSRRX (13 years) vs VFIAX (24 years). GSRRX is a more actively managed with annual turnover of: 45.00 vs. VFIAX (2.00). GSRRX has a lower initial minimum investment than VFIAX: GSRRX (0) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 31.72 vs. GSRRX (19.35). VFIAX return over 5 years is better than : 90.47 vs. GSRRX (23.98).
GSRRXVFIAXGSRRX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years24 years-
Gain YTD14.28619.97172%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets499M1.24T0%
Annual Yield % from dividends2.561.32194%
Returns for 1 year19.3531.7261%
Returns for 3 years3.6530.9912%
Returns for 5 years23.9890.4727%
Returns for 10 years-28.71190.48-15%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLBD54.491.17
+2.19%
Blue Bird Corp
MPLX44.200.07
+0.16%
Mplx LP
AIP7.45-0.08
-1.06%
Arteris
FFIN38.10-0.74
-1.91%
First Financial Bankshares
TPST1.35-0.06
-4.26%
Tempest Therapeutics